Laura Russo
US Patient Engagement Lead Pfizer
Laura Russo, the US Pfizer Patient Engagement Lead, is dedicated to collaborating with colleagues and partners to deliver breakthroughs that transform the lives of individuals living with chronic conditions and rare diseases. These challenges can be debilitating, and the societal burden is immense. This drives Laura and the entire team at Pfizer Specialty Care every day.
With nearly two decades of experience in national and rare disease sectors across various functions such as sales, patient advocacy, payer channels, access marketing, and operations at Pfizer, Laura is invigorated by the opportunity to partner with cross-functional teams and drive innovations that significantly impact those living with chronic or rare conditions. Her career journey has provided a comprehensive perspective on the pharmaceutical industry, enhancing patient education and access. She has also excelled in building and leading high-performing, inclusive teams that are shaping the future of market introductions for their products.
Currently, Laura is thrilled to contribute to the hope and future of Pfizer’s innovative treatments in Specialty Care. Her 27 years at Pfizer have been transformative. The experiences, people, and opportunities have guided her into a role that aligns with her personal values, and she is deeply grateful for the incredible journey thus far.
Seminars
- Quantifying patient connection and activation through opt-in rates, sustained navigator engagement, and community-specific adoption trends
- Measuring educational impact using pre- and post-program analytics that capture increases in treatment awareness, confidence, and intention to initiate therapy
- Using compliant, aggregated CRM insights to track behavior change, treatment comprehension, and community-level patterns while navigating legal and data-sharing constraints
- Translating these insights into clear, evidence-based narratives that demonstrate value, secure leadership buy-in, and guide resourcing decisions for scalable patient-focused models